Symptoms And Treatment Of Copd

I will analyse the prevalence of the condition and what the potential causes may be. My interests have been directed to pre hospital care and community lead treatment packages, which are potentially available to the patient, as this is the acute environment, which I will have contact with in my employment as a paramedic. The initial reading was to understand COPD as a chronic condition, what is COPD? and its prevalence in the population. The (World health organisation, 2000), states that one in four deaths in the world are caused by COPD. In 2010 (Vos T Flaxman etal, 2012), says globally there were approximately 329 million, which is 4.8% of the population who are affected by this chronic condition, In the UK (NICE, 2010), have estimated that 3 million people suffer from COPD, with more yet to be diagnosed. This information about the amount of people living with this condition was surprising, as I little knowledge of its existence. During the early 1960’s (Timothy Q. Howes, 2005), says the term COPD had been designated as a single term unifying all the chronic respiratory diseases. Since then the term COPD, has been sub divided in to three umbrella areas, Bronchitis, Emphysema and Chronic asthma, which are separate conditions, which I have been previously aware of as their individual conditions. The 58 year old patient who we visited,

There are no cure for this disease. However, there are different treatment to prevent further deterioration of the lungs function in order to improve the quality of life of the patient by increasing capacity of their physical activity. One of the main severe complication a patient with COPD can develop is exacerbation. Increased breathlessness, increased sputum volume and purulent sputum are the signs and symptoms of exacerbation. Early detection of the signs of exacerbation can help keep the condition of the patient from worsening. The treatments of COPD mainly aims at controlling the symptoms of exacerbation such as taking inhalers. Patients who are over the age of 35 and ex-smokers with chronic cough and bronchitis are recommended to have spirometer (NICE, 2004). This is because it is possible to delay or prevent patients from developing severe case of COPD is identified before they lose their lungs functions. Oxygen therapy is another treatment for COPD as the patients with this condition has high

R.W. appears with progressive difficulty getting his breath while doing simple tasks, and also having difficulty doing any manual work, complains of a cough, fatigue, and weight loss, and has been treated for three respiratory infections a year for the past 3 years. On physical examination, CNP notice clubbing of his fingers, use accessory muscles for respiration, wheezing in the lungs, and hyperresonance on percussion of the lungs, and also pulmonary function studies show an FEV1 of 58%. These all symptoms and history represented here most strongly indicate the probability of chronic obstructive pulmonary disease (COPD). COPD is a respiratory disease categorized by chronic airway inflammation, a decrease in lung function over time, and gradual damage in quality of life (Booker, 2014).

History of Present Illness: Ms. Manock is a very pleasant 60-year-old woman with a history of severe COPD. She was previously seen by Elvira Aguila, MD. Her last office visit was in February 2015. Since that time, she states that over the last few weeks, she feels her dyspnea has worsened which is a result of increased humidity, which is normal for her. She has had a stable cough over the last six months, which is intermittently productive of sputum. She is using her supplemental oxygen at 2 L/minute with exertion and with sleep. She also notes postnasal drip, which is related to seasonal allergies.

Chronic obstructive pulmonary disorder, or COPD, is a relatively common chronic illness that is treatable, however there is currently has no cure. COPD is an illness that encompasses two major illnesses these illnesses are chronic bronchitis and emphysema. Both of these illnesses wreak havoc on the lungs of the affected person by causing mucus to build up in the bronchioles henceforth reducing the effectiveness of the alveoli which impairs gas exchange. According to the American Lung Association, “COPD is the third leading cause of death in the United States. More than 11 million people have been diagnosed with COPD, but an estimated 24 million may have the disease without even knowing it” (American Lung Association [ALA], n.d.). As this data from the American Lung Association shows, in the United States alone we may have a total of 35 million people (almost one tenth of the American population) living with COPD. QSEN, which stands for Quality and Safety Education for Nurses, has developed six competencies related to nursing care. These competencies are Patient-Centered Care, Teamwork and Collaboration, Evidence-Based Practice, Quality Improvement, Safety, and Informatics. These aforementioned QSEN competencies break down how nurses should be treating patients and working with the health care team.

Shortness of breath and wheezing are classical signs of COPD. The first part of the essay is discussed on pathophysiology of COPD. Another part is going to be informing on the pharmacology aspect of treating the disease. Nutrition also plays as a critical component of relieving the symptoms of the disease or aiding the work of medication. One of the signs that COPD can be established as a primary cause of illness is by receiving lab report on Arterial Blood Gases ABG.

History of Present Illness: Mr. Magnuson is a very pleasant 77-year-old gentleman who was previously seen in this office by Elvira Aguila, MD for COPD and hypoxic respiratory failure. He is here today for routine followed up. He was last evaluated in January 2015. Since that time, he states that his dyspnea is worse. He feels that it is related to the weather. He does state that he works around the house, although he does have significant functional limitations because of shortness of breath. His wife also confirms that he is able to do less and less. He has a stable, minimal cough. He is using 4L of oxygen at night as well as, as needed throughout the day. He continues to smoke three to four cigarettes on

How would you describe the pathophysiology of COPD and comorbid heart failure to Charlie, considering that he has no medical knowledge/background?

Your topic is very interesting, when I practice as an ICU nurse I nursed many patients admitted with COPD exacerbations due to different etiology including unknown causes. I believe you bring up a very good point about not only obtaining an informed consent, but also offer education to the patients willing to participate in this research project. This is such a great intervention as the inform consent does not meet the educational needs required to provide full understanding of why this research needs to be completed and the benefits, and the impact that may have among this population. I am earger to read about your findings!! Great

The effectiveness of Family Support Caregiver in improving the Functional Status of Client with Pulmonary Diseases.

Medicines officially utilized as a part of the treatment of COPD may likewise be valuable in some comorbid ailments. New treatments ought to likewise be considered as conceivably helpful to systemic appearances and comorbidities. For instance, a viable breathed in calming treatment may enhance comorbidities by diminishing the overspill of fiery go-betweens from the lung that add to systemic aggravation. On the other hand, an oral calming treatment, and additionally smothering aggravation on the respiratory tract, may straightforwardly decrease systemic irritation. Obviously, a great deal more clinical and essential research is expected to comprehend the unpredictability of COPD so that more successful administration of COPD and its different comorbidities is conceivable later

All over the world, chronic obstructive pulmonary disease (COPD) is a very significant and prevalent cause of morbidity and mortality, and it is increasing with time (Hurd, 2000; Pauwels, 2000; Petty, 2000). Due to the factor of COPD being an underdiagnosed and undertreated disease, the epidemiology (Pauwels, Rabe, 2004) is about 60 to 85 % with mild or moderate COPD remaining undiagnosed (Miravitlles et al., 2009; Hvidsten et al., 2010).

The World Health Organization (WHO) (2006A) defines COPD as a disease state characterized by airflow limitation that is not wholly reversible. The airflow limitation is usually both progressive and associated with abnormal inflammatory response of the lungs to noxious particles or gases. John's chronic bronchitis is defined, clinically, as the presence of a chronic productive cough for 3 months in each of 2 successive years, provided other causes of chronic cough have been ruled out. (Mannino, 2003). The British lung Foundation (BLF) (2005) announces that chronic bronchitis is the inflammation and eventual scarring of the lining of the bronchial tubes which is the explanation for John's dyspnea. The BLF (2005) believe that when the bronchi become inflamed less air is able to flow to and from the lungs and once the bronchial tubes have been irritated over a long period of time, excessive mucus is produced. This increased sputum results from an increase in the size and number of goblet cells (Jeffery, 2001) resulting in John's excessive mucus production. The lining of the bronchial tubes becomes thickened and an irritating cough develops, (Waugh & Grant 2004) which is an additional symptoms that john is experiencing.

The pharmacologic treatment of COPD includes bronchodilators. Medication such Albuterol, levalbuterol, and ipratropium, are bronchodilator that comes in inhalant or liquid form that you add in to nebulizer. These medications relax the muscles around your airways. Anti-inflammatories are also used to help reduce the swelling and mucus production inside the airways. “Drugs used to treat asthma and COPD include drugs to block inflammation and drugs to dilate bronchi”(Karch, 2013, p. 941). Oxygen therapy is use as additional therapy for COPD patients. Managing the exacerbations includes treatment such as antibiotic, because bacterial or viral infection can cause exacerbation. Flu and Pneumococcal vaccination is also recommended to COPD

Silicosis is a chronic lung disease where silica particles have been inhaled and invaded lung tissue, causing the development of fibrous tissue. For silicosis to be caused it is necessary for silica dust to be inhaled for a long time, usually several years and this can be through hard rock and coal mining, quarrying and production of quartz (Dart, 1946). Symptoms of silicosis include chest pain, cough, respiratory problems, fever, weight loss and tiredness (Pneumoconiosis.org, 2015). This lung disease is incurable because the damage to the lungs that has taken place is irreversible so the main aims are to maintain quality of life and slow the deterioration. Bronchodilator medicines can be prescribed to relax lung muscles and help breathing and also oxygen therapy may be obtainable if there are very low oxygen levels in the body due to breathing difficulties. In severe cases a lung transplant may be available (NHSChoices, 2013). Prognosis depends on how serious the silicosis is, because the symptoms are progressive a person may live for a few months after diagnosis or could live for up to several years (Nall, 2013).